Gerovital H3 Romania

Depression represents one of the major problems as the years go.
Depression is a syndrome, a series of symptoms, involving physiological, emotional and cognitive transitions.

Depression Symptoms.
Diagnostic and Statistical Manual of Mental Disorders of the American Psychiatric Associations established a list of symptoms for depression breakdowns:
- change in food appetite;
- modifications in body weight;
- sleep disturbances;
- body constrictions and delayed kinetic responses;
- fatigue and lack of energy;
- anxious, fearful, tense and nervous states;
- memory and concentrations disorders;
- dislike, indifference and aversion for any kind of activity;
- tendency for guilt;
- thought or attempt of suicide;

The presence of 5 symptoms (of 10) shows depression.

Risk factors for Depression.
Principles that increase the occurrence of depression in the elderly include: being female, unmarried (especially if widowed); stressful and solicitant life events; deficit of supportive social network. Having physical conditions like Stroke, Hypertension, Atrial Fibrillation, Diabetes, Cancer or Dementia further aggravates the risk of clinical depression.

The risk factors often see in seniors are:
- certain medicines or combination of drug;
- other disorders and illnesses;
- social disconnection and living alone;
- recent loss of loved one;
- presence of a chronic and severe pain;
- deterioration of the body image (from amputation, cancer surgery, heart attack);
- previous history of depression;
- family cases of major depressive disorders;
- fear of death;
- past suicide attempts;
- substance abuse;

In younger years, depression is ignored. Both physician and patient are concerned about physical diseases.
But, in the old ages, depression develops within a complicated and complex clinical and social context. The patient frequently experience 2, 3 or even more maladies; most of these are related to body infirmity. Also, a fundamental cause for depressive states is that the social relationship doesn’t exist anymore due to the death of a spouse, retirement and/or relocation of residence.
Studies issued that at least 30% of old people are depressive. Others claimed a higher rate – 50%. The percentage progresses as the age increases.
But, these disturbances often remain undisclosed, being hidden under physical sickness. Although, the science and diagnosis expanded to unexpected and remarkable limits, many directions in depression are still unknown.

Age, Illnesses and Depression
Depression in seniors is not considerably different from adult’s depressive state.
But, in the late-life it coexists with multiple medical illnesses and disabilities. The somatic age collapses (cardiovascular, digestive, respiratory, weight loss) set a lot of inquiries for establishing a correct analysis and diagnosis.
Any depressive symptom may undermine life’s quality and life itself. So, a therapy is mandatory.

In 1945, Dr. Aslan started to treat with Procaine injections the patients with painful Arthritis, for healing their joints pain. Many patients showed an improved memory status, less depression, increased energy and a general well-being condition.
These conclusions determined her to continue to study the effects of Procaine on thousands of patients. She realized that by adding an antioxidant to Procaine, the effects were better. So, she did that and she called the improved formula ‘Gerovital H3’. From that period, Gerovital H3 was included on Pre-Geriatric and Geriatric class of medicines and considered a rehabilitator for the aged ones.

Gerovital H3 – Anti-Depressive Therapy

Gerovital H3 improves cells metabolism and has regenerative effects on mental and physical functions of the body. It ameliorates concentration and vitality; it reduces body inflexibility, enhances well-being and acts as an antidepressant.
Gerovital H3 represents a reversible inhibitor of the brain enzyme MAO (Monoamine Oxidase), the substance that increases with age and breaks down neurotransmitters, having so a destructive affect on brain function.

Beginning at 40, for fighting against aging and to prevent chronic ailments, it may be started a precautionary therapy,

PROTOCOL for PREVENTION (Pills Management).
2 tablets/day for 12 days; then, a break for 2 weeks.

- 1 Gerovital H3 pill in 2 hours after breakfast (ex: breakfast at 08.00am, pill at 10.00 am);
- 1 Gerovital H3 pill in 2 hours after lunch (ex: lunch at 12.00, pill at 04.00 pm);

In one year, the schedule consists in 5 series of 25 pills with appropriate breaks.
The plan can be changes to 6 series, if required.

To increase the regenerative actions, the therapy may combine pills with injections.

Gerovital H3 injectable therapy consists in 1.5-2.0mg/kg of body weight. This dose is one per day. This signifies 1 vial (ampoule) of Gerovital H3 per day.

PROTOCOL for REGENERATION and CURE (Pills & Injection Management).

- 3 Gerovital H3 injection/ week for 4 weeks;
- 2 weeks break;
- 2 Gerovital H3 pills/ day for 12 days;
- 2 weeks break;
Then resume the plan.http://www.blogger.com/img/blank.gif

Any other procedure or dose must be decided by the physician. The schedule must be adapted by taking under advisement the patient’s particularities: age and associated diseases.
If the patient forgets to one dose or more, the therapy should be lengthened.
Do not change the dose or schedule by your own decision.
Consult your doctor whenever considered necessary.
Consult your doctor if you think the drug effects are too high or to low.

Buy Online: http://www.markastore.com Official Online Romanian Gerovital products retailer

next: Arthritis and Gerovital H3.

Administration. Restrictions. Therapy Management.

Gerovital H3 is part of the class of drugs that act upon the body, especially in depression, stress and overworking circumstances.
Also, its properties recommend the drug for treating the degenerative diseases (Rheumatism, Arthritis, Parkinson, Arteriosclerosis).

Gerovital H3 is suitable beginning at 40, for holding back and for reversing the aging processes in the human body.

The therapy has both prophylactic and curative directions.
It can be used as a single drug therapy or it can be associated with other medicines.

Gerovital H3 Administration:

The drug must be administrated 2 hours after the meals (either oral or IM-intramuscular injection). After injection, a 10-15 minutes rest is required.

Gerovital H3 Restrictions:

Not recommended in the following cases: severe hepatic conditions; renal failure; severe arterial high blood pressure; febrile states.
It should not be combined with Physostigmine (Eserine), Prostigmin and Sulphamides.

*Physostigmine (Eserine) is a crystalline alkaloid used in medicine as a miotic and cholinergic agent and to enhance memory in patients with Alzheimer's disease.

*Prostigmin is a parasympathetic drug that acts as a reversible inhibitor to acetylcholinesterase, an enzyme which breaks down acetylcholine (ACh) in cholinergic nerve endings. It is used clinically to treat Myasthenia Gravis, Paralytic Ileus and Urine Retention.

*It is advisable not to apply Gerovital H3 in the same time with Sulphamides, because the interaction in the bacterial metabolism.

Consult your physician, especially:
- if you suffer from any disease;
- if you have any form of allergy;
- if you are self-medicating;

Take an allergy test before you start an injection cure.

First, take an ID intradermal injection (1 ml). Also, an IM intramuscular test (2ml).
These tests should reveal any possible allergy to Procaine.

The therapy with Gerovital H3 should be conducted under medical examination, especially at the beginning, in the first sequences of injections. The physician is able to determine an appropriate dose and eventually change, reduce or cancel other medication previously taken.

Gerovital H3 Therapy Management:

Gerovital H3 pills therapy involves 2 tablets per day.

Beginning at 40, for fighting against aging and for preventing chronic illnesses, it may be started a protective therapy,

SCHEDULE for PREVENTION (Pills Management).
2 tablets/day for 12 days; then, a break for 2 weeks.

- 1 Gerovital H3 pill in 2 hours after breakfast (ex: breakfast at 08.00am, pill at 10.00 am);
- 1 Gerovital H3 pill in 2 hours after lunch (ex: lunch at 12.00, pill at 04.00 pm);

In one year, the schedule consists in 5 series of 25 pills with appropriate breaks.


Gerovital H3 injectable therapy consists in 1.5-2.0mg/kg of body weight. This dose is one per day. This signifies 1 vial (ampoule) of Gerovital H3 per day.

SCHEDULE for REGENERATION and CURE (Pills & Injection Management).
- 3 Gerovital H3 injection/ week for 4 weeks;
- 2 weeks break;
- 2 Gerovital H3 pills/ day for 12 days;
- 2 weeks break;
Then resume the plan.

Any other procedure or dose must be decided by the physician. The schedule must be adapted by taking under advisement the patient’s particularities: age and associated diseases.
If the patient forgets to one dose or more, the therapy should be lengthened.
Do not change the dose or schedule by your own decision.
Consult your doctor whenever considered necessary.
Consult your doctor if you think the drug effects are too high or to low.

Gerovital H3 Side Effects:

In rare situations, at the beginning of the therapy, the patient may notice slight vertigo, cephalic heat perception or metallic taste. These disappear during the treatment.
Even after the allergy tests you observed none but later, during the injection therapy, it shows a cutaneous (dermal) reaction, immediately see your doctor.

Important to keep in mind:

- the drug must be administrated after meals;
- after taking an injection, a 10-15 minutes rest is mandatory;
- the product should be stores in a dry place, at room temperature;
- respect the validity date mentioned on the product;
- keep out of children’s reach;

Buy Online:  markastore.com - Official Romanian Gerovital Products retailer

next: Age and Depression. Therapy.

Cutaneous ageing it`s a slowly process , that
starts it` s clinical change perfidious after the
age of 35.

The mainly cause of cutaneous ageing process
is the accumulation of superoxyds (free acids) :
superoyds ions, the hydroxide anion, peroxide of hy-
drogen and the singhalet oxygen.

The free radicals can appear after the cells oxidoreduc-
tion process during the human body normal methabo-
lism, but also they can appear after exhibiting to envi-
ronment pollution, noxas, smoking,
uV radiations, alchool and drugs consmption, after
swells.

The cutaneous ageing is the consequence of two pro-
cesses : the extrinsic ageing ( photo ageing) and the
intrinsic ageing ( the chronological one).
the chronological one has a genetic propensity .
the ageing skin is clinical characterised by losingit`s
normal texture, tonus, resilence and firmness.
the skin becomes thin, translucid and that makes possi-
ble seeing the undernith dilated vessels, that lost their
resilience: teleangiectasia.

It becomes dryed, serous because of the substraction
of sebaceous and sudoriparous secretion with an im-
portant role for maintaining the protective, hidrolipidic
lubricant cutaneous film that ensures skin`s flexibility
and a ph of 4, - , .

It has a pigmentation which is not homogenous -
through the appearance of the lentigo, actinic Kera-
tosis and seborrhoeic Kerastosis especially when one
expose to the sun radiations.

After that we can see the wrinkles: expression wrinkles
and then the deep ones. after losing the hypodermic
grease the cheeks and the eyes widen, the eyelids fall,
it appears the goitre, the superiour lip becomes thin,
the skin looks flabby, depened, and we can see grossly
and vertical wrinkles arond the lips .
the clinical manifestations are the consequence of the
next pathological changes:
● at the epidermic level the capacity of cells renovation
goes down, the epiderm is thin.
● the dermic level is characterised by the decrease of
the collagen and elastic fibras which is caused by fibro-
blasts and growth of colagenosis and methaloprotei-
nasis activity, and also growth of glycosided collagen
the cause for cells death, the derm is atrophied.
● the pigmentattion changes are the consequence of
the lipofuscines accumulation in fibroblasts and the
oresence of melanic cells at the demo-epidermial junc-
tion.

The causative for the superficial wrinkles is the elastic
fibras deterioration.
the expression wrinkles are the consequence of facial
repeated movement with the secondary and frequency
contractions of facial muscles, and from the morfo-
pathological point of view it`s the densification ofder-
moepidermical junction.

The deep wrinkles are caused by the deterioration of
the elastic fibras.
The gravitational wrinkles appear after losing the resi-
lence of the skin and of the cellular hypodermic tissue
the adipose tissue is slided, and the derm is relaxed.

Visit Gerovital H3 Romanian store: markastore.com

Romanian Anti Aging Magazine
Cornelia Rusu, Daniela Gradinaru, Claudia Borsa, Cristina Ionescu
“Ana Aslan” National Institute of Gerontology and Geriatrics, Bucharest, Romania


Ever since 1952, multidisciplinary research on
aging in romania has been initiated as a priority
by professor dr. ana aslan. the priority lies in
three directions established for gerontological research
and acknowledged worldwide since then: clinical in-
vestigations, experimental research and social sciences
research.

At the same time, a large prophylaxis campaign with
Gerovital H3 (GH3) (procaine hydrochloride-2%, ben-
zoic acid-0.12%, disodium phosphate-0.01% and potas-
sium metabisulphite-0.10%, pH 3.3) and Aslavital (pro-
caine hydrochloride-2%, benzoic acid-0.12%, disodium
phosphate and L-glutamic acid potassium salt-1.2% and
potassium metabisulphite-0.10%, pH 3.3) - as procaine
based medication - was launched in the sixties and sev-
enties.
Ana Aslan envisaged and discovered procaine therapeu-
tic actions subsequent to long term treatment in low
doses with curative and preventive roles. as certified
by physicians and researchers, gh and aslavital had
been more effective than procaine from the point of
view of tolerance and efficacy. at cellular and molecu-
lar levels, procaine and its metabolites action sites are
multiple. procaine binds to membrane constituents and
interacts in a series of ion channels.

The compound has influence on metabolic pathways
involving intracellular signal molecules. primary and
secondary metabolites of procaine participate as pre-
cursors in synthesis of essential molecules for cellular
metabolism. procaine, gh and aslavital have antioxidant action:
inhibit reactive oxygen species generation
and lipid peroxidation in enzymatic and nonenzymatic
systems associated with a modulating effect on anti-
oxidant enzymes. gh and aslavital exert their action
on the atherogenesis process by lipid and lipoproteins-
lowering effects, procaine action on the erythrocyte
membrane and by antioxidant mechanisms. gh and
aslavital could be included in the category of revers-
ible and competitive mao inhibitors.

Their clinical use was warranted in studies of depres-
sion carried out in late eighties. gh and aslavital
modulate mechanisms of aging at cellular and molecu-
lar levels, as well as common mechanisms of chronic
degenerative age related diseases. these two romanian
drugs may be considered as marking the next great era
in gerontoprophylaxis.

Find Ana Aslan cosmetics online at markastore.com.

Anti-Aging Therapy with Gerovital H3.

Recommendations.
Effects.
Administration.
Precautions.

After the age of 40, therapy with Gerovital H3, pills and injections, can be started.
Gerovital H3 formula represents a proved method to hold back the aging process, an effective way to fight against and treat chronic degenerative diseases.

Gerovital H3 recommendations:

*Muscles and Joints Diseases: Degenerative Diseases, Arthritis, Osteoarthritis, Rheumatoid Arthritis, Osteoporosis;
*Nervous System Diseases: Multiple Sclerosis, Parkinson’s disease and syndrome, Postapoplectic conditions;
*Skin Diseases: Scleroderma, Psoriasis, Ichthyosis (fish skin disease), Bronchial Asthma;
*Cardiovascular and Gastrointestinal Diseases;
*Tegument Dystrophies, Trophic Ulcers and Atonic Wounds;
*Depressive Syndromes (moderate and light);
*Deficit of attention, concentrating and cognitive process;
*Neural-vegetative disorders;
*Chronic fatigue syndrome and sleep disorders;
*Management of the sexual life.

Gerovital H3 effects:

*increases the desire to be active and useful;
*improves affective tone, physical and physic balance;
*reduces body rigidity, increases body flexibility and moving abilities;
*balances endocrine functions, stimulates oestrogen reappearance and androgens reactivation; ameliorates sex management;
*alleviates chronic disease symptoms;
*raises the quality of life by decelerating the rhythm of aging and having a substantial and valuable role in preventing chronic diseases;

Gerovital H3 administration:

PROPHYLACTIC Therapy with Gerovital H3 tablets:

To anticipate and restrain the chronic diseases of the seniority and to partially reverse the aging progress, a prophylactic therapy may start from the age of 40.

Series of 25 pills for 12 days, 2pills/day:
- 1 Gerovital H3 pill in 2 hours after breakfast (example: breakfast at 08.00am, pill at 10.00 am);
- 1 Gerovital H3 pill in 2 hours after lunch (example: lunch at 12.00, pill at 04.00 pm);

General therapy for one year consists in 5 series of 25 pills with adequate breaks, after every course.
This schedule may increase to 6 series for patients over 65 years.

CURATIVE Therapy with Gerovital H3 tablets and injections:
Before starting the therapy with injections, do the tests for allergy: first injection 1ml; after 24 hours, second injection 2ml.
If no allergic reactions appear, the therapy may proceed.
The reactions that may occur are: rash, itching, eruption, vertigo, headache, cephalic heating sensation or a metallic taste. In most cases, these body reactions show in patients over 80 years.
Studies have revealed that the intolerance appear in 1 of 7000 cases.

A healing and restorative therapy in degenerative chronic diseases involves a schedule of 6 cures of 12 injections and 5 cures of 24 pills during a year.

Schedule:
- 3 Gerovital H3 injection/ week for 4 weeks;
- 2 weeks break;
- 2 Gerovital H3 pills/ day for 12 days;
- 2 weeks break;

Then resume the schedule.
Note: After injection, the patient school rest for 10-15 minutes.

Gerovital H3 contraindications and limits of use:

This drug should not be put in practice together with Physostigmine (also called Eserine) – a crystalline alkaloid used in medicine as a miotic and cholinergic agent and to enhance memory in patients with Alzheimer's disease.
Also, it should not be combined with Prostigmin - a parasympathetic drug that acts as a reversible inhibitor to acetylcholinesterase, an enzyme which breaks down acetylcholine (ACh) in cholinergic nerve endings. It is used clinically to treat Myasthenia Gravis, Paralytic Ileus and Urine Retention.
It is advisable not to apply Gerovital H3 in the same time with Sulphamides, because the interaction in the bacterial metabolism.

Gerovital H3 therapy is not recommended in the following conditions: severe hepatic diseases; renal failure; severe arterial high blood pressure; febrile states.

Gerovital H3 precautions:

*Apply prudently in cases of epilepsy or high blood pressure.
*Studies revealed no situation of drug addiction.
*No evidence regarding human fetus risk.

Gerovital H3 over dosage:

Drug intoxication develops over 400mg IV (intravenous) rapid injection. It manifests as convulsions, low blood pressure, coma. At this time apply treatment for any acute intoxication. No chronic intoxication occurred in clinical studies and practice.

Gerovital Shop: http://www.markastore.com

next: Specifications for patients.

10 commandments.

Can we do something indeed?
Can we postpone the aging?
Can we reverse the age?
Can we, at least, delay it?


Or, should we train for the coming old age?

The great question of the science is ‘Why the human body age?’
We all know the fact that the cells totally renew every 7 years.
So, why the scares remain on the skin, why the wrinkles appear and, in the end, why do we age?

Many physicians asked that question, but the answer is still to come.
The same question changed completely the life and career of one of them, the Romanian Dr. Ana Aslan, a brilliant woman and a complex personality.
At the age of 50, from an Internist and Cardiologist Physician, Dr. Aslan started a new and exciting life in Geriatrics and Gerontology.

She tried her best to make human’s life easier, to improve the condition of the elderly and to consider them more that ‘the life’s broken toys’; in a few words, we can say Dr. Aslan tried to make real what we can only dare to dream: to live with dignity and pride, as long as we possibly can.

And she succeeded.
She was the first physician and scientist that raised the aging subject above the ordinary. She unlocked the door to another path: prevention and treatment of the old age.
She invented and patterned the best geriatric treatment, the world famous formula Gerovital H3.

For the first time, in 1956, Dr. Ana Aslan introduced the concept of GerontoProphylaxis. For us, this is a synthesis of recommendations for delaying the aging process and remaining healthy and active.

There can be found a lot of goals in our life to achieve them.
But, few of them, must be the most significant. We have to think and talk about them, we have to apply them, we have to obligatory achieve them.

1. Pay attention to what we are eating and how much water we drink, because the food is the secret to an extended healthy life.

2. Start to move, because our body needs to be active.

3. Sex is recommended at any age.

4. In our minds and souls, we know the old age is coming. Sooner or later, better never. So, train for aging.

5. Think about a better way to live the days of aging. Act for that purpose.

6. Avoid the stress of any kind. It can never bring something good.

7. Loneliness causes depression. Depression causes loneliness. Resist and fight against them. Do something pleasant! Listen some music… that’s an idea!

8. Both internal and external health is important. For some internal conditions, they are still looking for solutions. For our look the solution is found: cosmetics.

9. Prophylaxis is ‘art and science’. Use it to prevent chronic diseases.

10. The drug of intelligence – Gerovital H3.


next: Gerovital H3 - Anti-Aging Therapy.

Pharmaceutical form: Injectable solution - intramuscular

Composition:
One ampoule contains:
- Procaine hydrochloride (100 mg)
- Benzoic acid (6 mg)
- Disodium phosphate dodecahydrate (0.5 mg)
- Potassium metabisulfite (5 mg)
- Distilled water for injectable solutions (up to 5 ml)

Pharmacotherapeutic group: Alimentary tract and metabolism. Tonic preparations. ATC code: A13 AN01

Therapeutic indications:
DEPRESSIVE SYNDROME: light and moderate depression, in precocious stages, especially when conventional therapy is not well-tolerated or it has contraindications;
PARKINSONIAN SYNDROMES: where it can be used in monotherapy or associated with other antiparkinsonian drugs, especially with dopaminergic agents;
OSTEOARTHRITIS: chronic degenerative rheumatism;
SYSTEMIC ARTERIOSCLEROSIS: with hypercholesterolemia, ischaemic heart disease, arteritis, cerebral atherosclerosis;
PROTECTION AGAINST AGING PHENOMENA;


Posology and method of administration:
Before starting the treatment with Gerovital® H3 it is compulsory to test individual sensitivity to procaine, as follows: 1 ml from the injectable solution of Gerovital® H3 will be administered subcutaneously and after 24 hours the test should be repeated with 1.5 ml solution intramuscularly. If any allergic reaction occurs, the treatment is not recommended.

DEPRESSIVE SYNDROME:
Injectable solution:
1-st week: 1 ampoule (5 ml) intramuscular injection/day, 3 times a week (i.e., on Monday, on Wednesday and on Friday);
2-nd week: 1.5 ampoules (7.5 ml) intramuscular injection/day, 3 times a week;
3-rd week: 1.5 ampoules (7.5 ml) intramuscular injection/day, 3 times a week;
4 - th week: 2 ampoules (10 ml) intramuscular injection/day, 3 times a week.
The treatment should be repeated 4-6 times a year.
Total treatment: aprox 110 ampolules/year

PARKINSONIAN SYNDROMES:
Injectable solution: 1 ampoule (5 ml) intramuscular injection/day for 15 days
Total treatment: aprox 180 ampolules/year
Sugar-coated tablets: 2 tablets/daily for 15 days
Total treatment: aprox 360 tablets/year

OSTEOARTHRITIS:
Injectable solution: 1 ampoule (5 ml) intramuscular injection/ day, for 15-21 days and then
1 ampoule (5 ml) intramuscular injection/3 times a week (every other day), for 4 weeks;
The treatment should be repeated 4-5 times a year.
Total treatment: aprox 160 ampolules/year
Sugar-coated tablets: during the pauses in injections series, 1-2 tablets/day for 12-18 days/month, can be administrated.
Total treatment: aprox 180 tablets/year

SYSTEMIC ARTERIOSCLEROSIS:
Depending of the intensity and the localization of the process, the treatment should be as follows:
Injectable solution: 1 ampoule (5 ml) intramuscular injection/day 3 times a week for 4 weeks.
The treatment should be repeated 5-6 times a year.
Total treatment: aprox 72 ampolules/year
Sugar-coated tablets: between the injections series, oral treatment may be added - 2 sugar-coated tablets/day, 12 days.
Total treatment: aprox 150 tablets/year
Sugar-coated tablets: in some cases the treatment can be exclusively oral; 3 sugar-coated tablets/day, 21 days in 6-8 series/year
Total treatment: aprox 500 tablets/year

PROTECTION AGAINST AGING PHENOMENA:
Injectable solution: 1 ampoule (5 ml) intramuscular injection/day, 3 times a week (one ampoule every other day), over a period of 4 weeks
Total treatment: aprox 100 ampolules/year
Sugar-coated tablets: 2 sugar-coated tablets/ day, after meals, in the morning and in the afternoon, for 12 days.
Total treatment: aprox 150 tablets/year
Series of injections and sugar-coated tablets should be alternated yearly, continuously or with one-month pause between them. The schedule and the frequency of pauses will be decided by the geriatrist, according with the aging status of the patient.


Contraindications:
*Hypersensitivity to procaine in antecedents or tested.
*Severe arterial hypotension.
*Associated treatment with sulfonamides (except the antidiabetic ones) and with acetylcholinesterase agents: neostygmine, eserine (physostigmine) and pyridostigmine.

Precautions regarding medicinal product administration:
Before starting the treatment, a test for individual tolerance to procaine should be made (see under Posology and method of administration).
The treatment must take place under medical supervision, mainly in the first series of treatment, in order to establish the optimal dose.
The product should be administered with caution in patients with orthostatic hypotension.
Although procaine medication is not carcinogenic, it is not recommended to the patients with cancer, as its stimulating effect on mitotic potential of the neoplasic cell is not excluded.

Interactions with other medicinal products or other substances:
Gerovital® H3 should not be administered simultaneously with sulphonamides (antagonistic mechanism of action) - except the antidiabetic ones, anticholinesterases: neostygmine, eserine (physostigmine) and pyridostigmine.

Special warnings:
Pregnant and breast-feeding women: the studies on animals did not show teratogenic effects. In absence of teratogenic effects on animals, malformative effects on humans are not expected. However, the clinical experience with Gerovital® H3 is mainly on patients over the procreation period. For these reasons we do not recommend the use of the product during pregnancy and lactation.
Potential effect on the ability to drive or to use machines: the product does not interfere with these abilities.

Adverse reactions, which can occur during the use of the medicinal product:
Administration of Gerovital® H3 may produce allergic reactions in patients with hypersensitivity to procaine like skin rash or pruritus.
These effects impose an immediate stop of the treatment.
Minor effects may occur especially at the beginning of the treatment like: dizziness, weakness and palpitations. These effects can be avoided if after the injection the patient rests in bed for 10-15 minutes.

Overdose:
There are no reports of overdose related to administration of Gerovital® H3. In case of accidentally injection of high doses, severe hypotension, convulsions, coma, respiratory arrest may occur.
The treatment is symptomatic and support of vital functions.

Storage:
*Store below 25 C.
*Keep out of the reach of children.
*Do not use after the expiry date printed on the package.


Packaging:
Folding box with 5 brown ampoules of 5 ml

Manufacturer, name and country:
ZENTIVA N.V., Romania.

Buy Online:
markastore.com - official retailer

Researchers from Farmec SA Cluj Romania go beyond struggle and achievements Prof. Ana Aslan, replacing H3 with a triad of innovative active principles that are slowing the aging process acting more specifically on key biological processes.
All current research in molecular biology to identify leading 3-way to aging skin
- Sunlight aging (oxidative stress caused by sunlight)
- Reactive radical species, which cause structural and functional mutations of cell membranes, alteration of fatty acids, protein and cellular DNA.
- Decreased mitochondria to generate and store energy in molecules of ADP

Mechanism of action

Evolution Gerovital H3 range is specially designed to slow down all 3 mechanisms of aging skin and to counteract the effects of long-term, using 3 active principles direct action:

SOD, dubbed "anti aging super-enzymes", ensure long-term skin firmness, acting against oxidative degradation and protecting fibroblasts chains of collagen and elastin proteins responsible for skin elasticity. SOD is the most active naturally occurring antioxidant enzymes.
Trylagen acts against wrinkles and ensure a smooth skin, more flexible, stimulating production of new collagen and elastin fibers, which constitute support for synthesis.
GP4G regenerated skin from the inside, a source of pure energy that makes up less capacity of cells to generate and store energy.

GH3 Evolution Concept
In this complex the most important element that appears on the front of packaging products is SOD (superoxide dismutaza) called generic Anti Aging Super Ensyme. This complex is associated with other active principles depending on the destination of each product.
Evolution products Gerovital H3 range is structured in two age groups to meet specific requirements such differentiated.
Products for women aged over 30 years of combat the first signs of aging: fine lines around the eyes and mouth, dark circle and bags under the eyes, loss of skin brightness. The structures of these products are lightweight and provides an immediate feeling of comfort and lasting hydration.
Products for women aged over 45 are designed to solve complex problems caused by sun aging and lower production of estrogen around menopause: accelerated loss of skin elasticity, deep wrinkles, decreased vitality and cell regeneration (turn - over cellular), the occurrence of pigment spots. The product range is rich in nutrients and give a feeling of emollient, a long-lasting hydration and a marked increase skin tone

Gerovital H3 Evolution products:
Tonifying Cleansing Milk
Tonifying Cleansing Water

Moisturizing Lifting Cream SFP15, age 30+
Regenerating Lifting Cream, age 30+
Calming Anti-Couperose Cream, age 30+
Enzymatic Exfoliant, age30+

Anti-Wrinkle Cream SPF15, age 45+
Anti-Aging Cream, age 45+
Dark Spots Corrector, age 45+
Perfect Anti-Aging Serum, age 45+

Buy online from markastore.com.

Gerovital Plant Forte - Treatment Scheme - Dry skin

Gerovital Plant Forte - Treatment Scheme - Oily Skin

Gerovital Plant Forte - Treatment Scheme - Normal Skin

Gerovital Plant Forte - Treatment Scheme - Body Care

If you are a new buyer of Gerovital products is very confusing because a lot of different products which are for sale over the internet.

Please have in mind that original Gerovital products are made only in Romania.

So we'll show you bellow few products who are not made in Romania and who are NOT ORIGINAL.



NOT ORIGINAL GEROVITAL H3 from Romania

NOT ORIGINAL GEROVITAL H3 from Romania

NOT ORIGINAL GEROVITAL H3 from Romania

NOT ORIGINAL GEROVITAL H3 from Romania

NOT ORIGINAL GEROVITAL H3 from Romania

NOT ORIGINAL GEROVITAL H3 from Romania

NOT ORIGINAL GEROVITAL H3 from Romania

NOT ORIGINAL GEROVITAL H3 from Romania



NOT ORIGINAL FROM ROMANIA

Hello,
We are starting this blog by teaching you how to make difference between a genuine Gerovital H3 and a fake one.
A lot of websites are offering fake products covered by cheap words like magic Gerovital tablets with guaranted results in two days or "Prof Ana Aslan new anti aging suplemet - works 300% faster".

The Golden Rule for discovering the original Gerovital Products is:
ALL GEROVITAL PRODUCTS ARE MADE IN ROMANIA

Only two companies (both from Romania) are allowed to produce Gerovital H3 products:
1. SC FARMEC SA (All Gerovital Cosmetics)

Gerovital H3 Prof. Dr. Ana Aslan Cosmetics Series:

1967 Prof. Dr. Ana Aslan Gerovital H3 line









1998 Prof. Dr. Ana Aslan Gerovital H3 line










2006 Prof. Dr. Ana Aslan Gerovital H3 line












2010 Prof. Dr. Ana Aslan GerovitalH3 Evolution line

2013 Prof. Dr. Ana Aslan GerovitalH3 Classic line












2013 Prof. Dr. Ana Aslan GerovitalH3 Classic Retinol line








2014 Prof. Dr. Ana AslanGerovital H3 Men line












2014 Prof. Dr. Ana Aslan GerovitalH3 Derma+ line












2015 Prof. Dr. Ana Aslan GerovitalH3 Derma+ Sun line

Gerovital Plant Cosmetics Series

Alsalvital Series

2001














2012













2. ZENTIVA N.V. (Gerovital H3 Injectables and Gerovital H3 Tablets)
Gerovital H3 Sugar-Coated Tablets




















Gerovital H3 Injectable Solution














Any other manufacturers are producing fake Gerovital H3 products.

Please be very careful when you are buying Gerovital and contact us if is a real or a fake.

We recomment for shopping and getting news about Gerovital the following websites:
1.http://www.farmec.ro - Official website of SC Farmec SA the Romainan Gerovital H3 cosmetics producer
2.http://www.zentiva.ro - Official website of SC Zentiva SA from Bucharest the Gerovital H3 Injectables and Tablets producer
3.http://www.markastore.com - the traditional store for Romanain Cosmetics